Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.660
+0.190 (7.69%)
At close: Aug 13, 2025, 4:00 PM
2.660
0.00 (0.00%)
Pre-market: Aug 14, 2025, 4:55 AM EDT
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $55.82 million as of August 14, 2025. Its market cap has decreased by -64.42% in one year.
Market Cap
55.82M
Enterprise Value
103.64M
1-Year Change
-64.42%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $55.82M, a decrease of -90.40%. That is a compound annual growth rate of -19.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 55.80M | -42.53% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |